or
forgot password

    • cancer clinical trials in sharon, CT

    • S-1 as Second-Line Therapy in Treating Patients With Unresectable or Recurrent Stage III or Stage IV Non-Small Cell Lung Cancer
    Northwestern Connecticut Oncology Hematology Associates - Sharon
    Sharon, Connecticut 06069
    Lung Cancer
    S-1 and Cisplatin as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
    Northwestern Connecticut Oncology Hematology Associates - Sharon
    Sharon, Connecticut 06069
    Lung Cancer
    Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
    Sharon Hospital
    Sharon, Connecticut 06069
    Non Small Cell Lung Carcinoma